liveBook · Manning

Crystallography

As explained in Build AI Drug Discovery Pipelines

Crystallography is a technique for determining molecular or material structures from the diffraction of radiation by crystals.

X-ray crystallography determines a protein’s structure by using diffraction from a crystal to infer an electron-density map. An atomic model is fitted into that map and refined, producing a practical receptor structure for drug-discovery workflows. section 9.1.1

Treat crystallographic structures as useful models rather than perfect molecular snapshots:

  • Account for alternative side-chain conformations, missing or disordered loops, ambiguous waters or ligands, and crystallographic artifacts when using the structure for docking. section 9.1.1
  • Use the resulting three-dimensional receptor structure with a ligand conformer and defined binding box as input to molecular docking. section 9.1.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Explains diffraction, electron-density fitting, refinement, and structural uncertainty, but stops short of experimental collection details.
Examples
Uses protein receptor structures, crystallographic poses, ambiguous ligands, and binding-box inputs as practical artifacts.
What you can do after
Evaluate crystallographic structures as docking inputs while accounting for their modeling uncertainties.
How it connects
Connects crystallographic structures to electron-density maps, atomic models, protein-ligand docking, and structure-based drug design.

Related concepts

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.